Advertisement

Stimulants pp 167-217 | Cite as

Drug Treatment in Child Psychiatry

  • Daniel J. Safer
Part of the Handbook of Psychopharmacology book series (HBKPS, volume 11)

Abstract

There are now over 20 review articles in pediatric psychopharmacology and they appear to be increasing in the 1970s (Sprague and Werry, 1971; Di Mascio et al., 1970; Renshaw, 1975; Freeman, 1970; Blackwell and Currah, 1973; Conners, 1972; Campbell, 1975b,c; Eisenberg and Conners, 1971; Greenberg and Lourie, 1972; Eveloff, 1970; Kornetsky, 1975). They function to simplify the process of keeping up with the ever-expanding number of papers in the field and to organize the numerous findings of separate studies.

Keywords

Anorexia Nervosa Child Psychiatry Nocturnal Enuresis Retarded Child Hyperactive Child 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adamson, W. C., Nellis, B. P., Runge, G., Cleland, C., and Killian, E., 1958, Use of tranquilizers for mentally deficient patients, AMA J. Dis. Child. 96:159–164.PubMedGoogle Scholar
  2. Alderton, H. R., 1970, Imipramine in childhood enuresis: Further studies on the relationship of time of administration to effect, Can. Med. Assoc. J. 102:1179–1180.PubMedGoogle Scholar
  3. Alexandris, A., and Lundell, F. W., 1968, Effect of thioridazine, amphetamine and placebo on the hyperkinetic syndrome and cognitive area in mentally deficient children, Can. Med. Assoc. J. 98:92–96.PubMedGoogle Scholar
  4. Al-Kaisi, A. H., and McGuire, R. J., 1974, The effect of sulthiame on disturbed behaviour in mentally subnormal patients, Br. J. Psychiat. 124:45–49.Google Scholar
  5. Aman, M. G., and Sprague, R. L., 1973, Effect of methylphenidate and dextroamphetamine on learning and retention, in Progress Report of Grant MH 18909 from 1970–1973 (R Sprague, Principal Investigator) (March, 1973).Google Scholar
  6. Aman, M. G., and Sprague, R. L., 1974, The state-dependent effects of methylphenidate and detroamphetamine, J. Nerv. Ment. Dis. 158:268–279.PubMedGoogle Scholar
  7. Andrews, G., and Harris, J., 1964, The syndrome of stuttering, Clin. Develop. Med. 17:160–167.Google Scholar
  8. Anthony, E. J., 1959, An experimental approach to the psychopathology of childhood: Sleep, Br. J. Med. Psychol. 32:19–37.PubMedGoogle Scholar
  9. Anton, A. H., and Greer, M., 1969, Dextroamphetamine, catecholamines, and behavior: The effect of dextroamphetamine in retarded children, Arch. Neurol. 21:248–252.PubMedGoogle Scholar
  10. Arieff, A. J., and Mier, M., 1966, Anticonvulsant and psychotropic action of Tegretol, Neurology 16:107–110.PubMedGoogle Scholar
  11. Ayllon, T., Layman, D., and Kandel, H. J., 1975, A behavioral-educational alternative to drug control of hyperactive children, J. Appl. Behav. 8:137–146.Google Scholar
  12. Bair, H. V., and Herold, W., 1955, Efficacy of chlorpromazine in hyperactive mentally retarded children, AMA Arch. Neurol. Psychiat. 74:363–364.Google Scholar
  13. Bakwin, H., 1973, The genetics of enuresis, Clin. Develop. Med. 48/49:73–77.Google Scholar
  14. Bakwin, H., and Bakwin, R. M., 1972, Behavior Disorders in Children, 4th ed., pp. 546–553. W. B. Saunders, Philadelphia.Google Scholar
  15. Balow, B., 1965, The long term effect of remedial reading instruction, Reading Teacher 18:581–586.Google Scholar
  16. Bamberger, P., and Matthes, A., 1966, Effect of Valium on seizures and eeg in different forms of childhood epilepsy, Electroenceph. Clin. Neurophysiol. 20:103.Google Scholar
  17. Ban, T. A., 1973, Haloperidol and the butyrophenones, Psychosomatics 14:286–297.PubMedGoogle Scholar
  18. Barker, P., and Fraser, I. A., 1968, A controlled trial of haloperidol in children, Br. J. Psychiat. 114:855–857.Google Scholar
  19. Barnes, M. R., and Fetterman, J. L., 1938, Mentality of dispensary epileptic patients, AMA Arch. Nenrol. Psychiat. 40:903–910.Google Scholar
  20. Barnett, C., and Lampert, R., 1957, Effects of Metrazol on intellectual functioning in defectives, Psych. Rep. 3:551–554.Google Scholar
  21. Beech, H. R., and Fransella, F., 1968, Research and Experiment in Stuttering, Pergamon Press, Oxford.Google Scholar
  22. Benady, D. R., 1970, Cyproheptadine hydrochloride (Periactin) and anorexia nervosa: A case reporter. J. Psychiat 117:681–682.Google Scholar
  23. Bender, L., 1953, Childhood schizophrenia, Psychiat. Quart. 27:663–681.PubMedGoogle Scholar
  24. Bender, L., 1970, Children’s reactions to psychotomimetic drugs, in Psychotomimetic Drugs (D. H. Efron, ed.), pp. 265–271, Raven Press, New York.Google Scholar
  25. Berger, M., Yule, W., and Rutter, M., 1975, Attainment and adjustment in two geographic areas II. The prevalence of specific reading retardation, Br. J. Psychiat. 126:510–519.Google Scholar
  26. Bird, C. A., Griffin, B. P., Miklaszewska, J. M., and Galbraith, A. W., 1966, Tegretol (Carbamazepine): A controlled trial of a new anti-convulsant, Br. J. Psychiat. 112:737–742.Google Scholar
  27. Blacklidge, V. Y., and Ekblad, R. L., 1971, The effectiveness of methylphenidate hydrochloride (Ritalin) on learning and behavior in public school educable mentally retarded children, Pediatrics 47:923–926.PubMedGoogle Scholar
  28. Blackwell, B., and Currah, J., 1973, The psychopharmacology of nocturnal enuresis, Clin. Develop. Med. 48/49:231–257.Google Scholar
  29. Blinder, B. J., Freeman, D. M., and Stunkard, A. J., 1970, Behavior therapy of anorexia nervosa: Effectiveness of activity as a reinforcer of weight gain, Am. J. Psychiat. 126:1093–1098.PubMedGoogle Scholar
  30. Bonduelle, M., 1972, My study of Tegretol in the treatment of epilepsy, in Tegretol in Epilepsy (C. A. Winc, ed.), pp. 80–88, C. Nicholls and Company, Manchester.Google Scholar
  31. Bradley, C., 1951, Behavior disturbances in epileptic children, JAMA 146:436–441.Google Scholar
  32. Breger, E., 1961, Meprobamate in the management of enuresis, J. Pediat. 59:571–576.PubMedGoogle Scholar
  33. Breger, E., 1962, Hydroxyzine hydrochloride and methylphenidate hydrochloride in the management of enuresis, J. Pediat. 61:443–447.PubMedGoogle Scholar
  34. Brett, E. M., 1973, Epilepsy in childhood, Br. J. Hosp. Med. 9:177–186.Google Scholar
  35. Broughton, R. J., 1968, Sleep disorders: Disorders of arousal? Science 159:1070–1078.PubMedGoogle Scholar
  36. Brown, D., Winsberg, B. G., Bailer, I., and Press, M., 1973, Imipramine therapy and seizures: Three children treated for hyperactive behavior disorders, Am. J. Psychiat. 130:210–212.PubMedGoogle Scholar
  37. Bruun, R., Shapiro, A. K., Sweet, R., Shapiro, E., Solomon, G., and Wayne, H., 1975, A follow-up study of Tourette’s syndrome in seventy-seven patients. Paper read at the Annual Meeting of the Amer. Psychiatric Assoc, Anaheim, California (May 9, 1975).Google Scholar
  38. Buchanan, R. A., 1972, Ethosuximide: Toxicity, in Antiepileptic Drugs (D. M. Woodbury, J. K. Penry, and R. P. Schmidt, eds.), pp. 449–454, Raven Press, New York.Google Scholar
  39. Burk, H. W., and Menolascino, F. J., 1968, Haloperidol in emotionally disturbed mentally retarded individuals, Am. J. Psychiat. 124:1589–1591.PubMedGoogle Scholar
  40. Campbell, M., 1975a, Clinical trials of TRH (thyroid releasing hormones), Psychopharm. Bull. 11 (Jan.): 19–20.Google Scholar
  41. Campbell, M., 1973, Biological interventions in psychoses of childhood, J. Aut. Child. Schiz. 3:347–372.Google Scholar
  42. Campbell, M., 1975b, Psychopharmacology in childhood psychosis, Int. J. Mental Health 4:238–254.Google Scholar
  43. Campbell, M., 1975c, Pharmacotherapy in early infantile autism, Biol. Psychiat. 10:399–423.PubMedGoogle Scholar
  44. Campbell, M., Fish, B., Shapiro, T., and Floyd, A., 1970, Thiothixene in young disturbed children, Arch. Gen. Psychiat. 23:70–72.PubMedGoogle Scholar
  45. Campbell, M., et al., 1971a, Imipramine in preschool autistic and schizophrenic children, J. Aut. Child. Schiz. 1:267–282.Google Scholar
  46. Campbell, M., et al., 1971b, Study of Molindone in disturbed preschool children, Curr. Therap. Res. 13:28–33.Google Scholar
  47. Campbell, M., Fish, B., David, R., Shapiro, T., Collins, P., and Koh, C., 1972a, Response to triiodothyronine and dextroamphetamine: A study of preschool schizophrenic children, J. Aut. Child. Schiz. 2:343–358.Google Scholar
  48. Campbell, M., et al., 1972b, Acute responses of schizophrenic children to a sedative and a “stimulating” neuroleptic: A pharmacologic yardstick, Curr. Therap. Res. 14:759–766.Google Scholar
  49. Campbell, M., Fish, B., Korein, J., Shapiro, T., Collins, P., and Koh, C., 1972c, Lithium and chlorpromazine: A controlled crossover study of hyperactive severely disturbed young children, J. Aut. Child. Schiz. 2:234–263.Google Scholar
  50. Campbell, M., et al., 1973, Liothyronine treatment in psychotic and non-psychotic children under 6 years, Arch. Gen. Psychiat. 29:602–608.PubMedGoogle Scholar
  51. Carter, C. H., 1959, Prochlorperazine in emotionally disturbed, mentally defective children, South Med. J. 52:174–178.PubMedGoogle Scholar
  52. Chapel, J. L., Brown, N., and Jenkins, R. L., 1964, Tourette’s disease: Symptomatic relief with Haloperidol, Am. J. Psychiat. 121:608–610.PubMedGoogle Scholar
  53. Christensen, D. E., 1975, Effects of combining methylphenidate and a classroom token system in modifying hyperactive behavior, Am. J. Ment. Defic. 80:266–276.PubMedGoogle Scholar
  54. Christensen, D. E., and Sprague, R. L., 1973, Reduction of hyperactive behavior by conditioning procedures alone and combined with methylphenidate (Ritalin), Behav. Res. Therap. 11:331–334.Google Scholar
  55. Cohen, M. W., 1975, Enuresis, Ped. Clin. N. Amer. 22:545–560.Google Scholar
  56. Connell, P. H., Corbett, J. A., Horne, D. J., and Mathews, A. M., 1967, Drug treatment of adolescent ticquers: A double-blind trial of Diazepam and Haioperidol, Br. J. Psychiat. 113:375–381.Google Scholar
  57. Conners, C. K., 1969, A teacher rating scale for use in drug studies with children, Am. J. Psychiat. 126:884–888.PubMedGoogle Scholar
  58. Conners, C. K., 1972, Pharmacotherapy of psychopathology in children, in Psychopathological Disorders in Childhood (H. C. Quay and J. S. Werry, eds.), pp. 316–347, Wiley, New York.Google Scholar
  59. Conners, C. K., 1973, Rating scales to use in drug studies with children, Psychopharm. Bull., Spec. Issue: Pharmacotherapy of Children, pp. 24-84.Google Scholar
  60. Conners, C. K., 1974, Drug and cognition studies in disturbed children, Psychopharm. Bull. 10 (April):60–61.Google Scholar
  61. Conners, C. K., 1975, Controlled trial of methylphenidate in preschool children with minimal brain dysfunction, Int. J. Mental Health 4:61–74.Google Scholar
  62. Conners, C. K., and Rothschild, G., 1968, Drugs and learning in children, in Learning Disorders Vol. III (J. Hellmuth, ed.), pp. 191–224, Spec. Child Publ., Seattle, Washington.Google Scholar
  63. Conners, C. K., Rothschild, G., Eisenberg, L., Schwartz, L. S., and Robinson, E., 1969, Dextroamphetamine sulfate in children with learning disorders: Effects on perception, learning and achievement, Arch. Gen. Psychiat. 21:182–190.PubMedGoogle Scholar
  64. Conners, C. K., Kramer, R., Rothschild, G. H., Schwartz, L., and Stone, A., 1971, Treatment of young delinquent boys with diphenylhydantoin sodium and methylphenidate: A controlled comparison, Arch. Gen. Psychiat. 24:156–160.PubMedGoogle Scholar
  65. Conners, C. K., Taylor, E., Meo, G., Kurtz, M. A., and Fournier, M., 1972, Magnesium pemoline and dextroamphetamine: A controlled study in children with minimal brain dysfunction, Psychopharmacologia 26:321–336.PubMedGoogle Scholar
  66. Conners, C. K., Goyette, C., and Southwick, D., 1975, Food Additives and Hyperkinesis: Preliminary Report of a Double-Blind, Cross Over Experiment, unpublished manuscript.Google Scholar
  67. Conrad, W. G., Dworkin, E. S., Shai, A., and Tobiessen, J. E., 1971, Effects of amphetamine therapy and prescriptive tutoring on the behavior and achievement of lower class hyperactive children, J. Learn. Disabil. 4:509–517.Google Scholar
  68. Cookson, I. B., and Wells, P. G., 1973, Haloperidol in the treatment of stutterers, Br. J. Psychiat. 123:491.Google Scholar
  69. Coolidge, J. C., Brodie, R. D., and Feeney, B., 1964, A ten-year follow-up study of sixty-six school-phobic children, Am. J. Orthopsychiat. 34:675–684.PubMedGoogle Scholar
  70. Corbett, J. A., Mathews, A. M., Connell, P. H., and Shapiro, D. A., 1969, Tics and Gilles de la Tourette’s syndrome: A follow-up study and critical review, Br. J. Psychiat. 115:1229–1241.Google Scholar
  71. Cordes, C. K., 1973, Chronic drug intoxication causing pseudoretardation in a young child, J. Am. Acad. Child. Psychiat. 12:215–222.Google Scholar
  72. Craft, M., 1975a, Tranquilizers in mental deficiency: Hydroxyzine, J. Mental. Sci. 103:855–857.Google Scholar
  73. Craft, M., 1957b, Tranquillizers in mental deficiency: Chlorpromazine, J. Mental Def. Res. 1:91–95.Google Scholar
  74. Craft, M., 1958, Tranquillizers in mental deficiency: Meprobamate, J. Mental Def. Res. 2:17–20.Google Scholar
  75. Craft, M., 1959, Mental disorder in the defective: The use of tranquillizers, Am. J. Mental Def. 64:63–71.Google Scholar
  76. Creak, M., et al., 1961, Schizophrenic syndrome in childhood, Br. Med. J. 2:889–891.Google Scholar
  77. Crisp, A. H., 1966, A treatment regime for anorexia nervosa, Br. J. Psychiat. 112:505–512.Google Scholar
  78. Crisp, A. H., and Kalucy, R., 1973, The effect of leucotomy on intractable adolescent weight phobia (primary anorexia nervosa), Postgrad. Med. J. 49:883–893.PubMedGoogle Scholar
  79. Cunningham, M. A., Pillai, V., and Rogers, W. J., 1968, Haloperidol in the treatment of children with severe behaviour disorders, Br. J. Psychiat. 114:845–854.Google Scholar
  80. Dalby, M. A., 1971, Antiepileptic and psychotropic effect of carbamazepine (Tegretol) in the treatment of psychomotor epilepsy, Epilepsia 12:325–334.PubMedGoogle Scholar
  81. Dally, P. J., and Sargant, W., 1966, Treatment and outcome of anorexia nervosa, Br. Med. J. 2:793–795.PubMedGoogle Scholar
  82. Davidorf, F. H., 1973, Thioridazine pigmentary retinopathy, Arch. Opthalmol. 90:251–255.Google Scholar
  83. DeJonge, G. A., 1973, Epidemiology in enuresis: A survey of the literature, Clin. Develop. Med. 48/49:39–46.Google Scholar
  84. DeLeon, G., and Mandell, W., 1966, A comparison of conditioning and psychotherapy in the treatment of functional enuresis, J. Clin. Psych. 22:326–330.Google Scholar
  85. Di Mascio, A., Soltys, J. J., and Shader, R. I., 1970, Psychotropic drug side effects in children, in Psychotropic Drug Side Effects (R. I. Shader, and A. Di Mascio, eds.), pp. 235–260, Williams and Wilkins, Baltimore.Google Scholar
  86. Eisenberg, L., 1958, School phobia: Diagnosis, genesis, and clinical management, Ped. Clin. N. Am. 5:645–666.Google Scholar
  87. Eisenberg, L., 1966a, The management of the hyperkinetic child, Develop. Med. Child Nenrol. 8:593–598.Google Scholar
  88. Eisenberg, L., 1966b, Reading retardation: Psychiatric and sociologic aspects, Pediatrics 37:352–365.PubMedGoogle Scholar
  89. Eisenberg, L., 1967, Psychotic disorders: Clinical features, in Comprehensive Textbook of Psychiatry (A. M. Freedman and H. I. Kaplan, eds.), pp. 1433–1438, Williams and Wilkins, Baltimore.Google Scholar
  90. Eisenberg, L., and Conners, C. K., 1971, Psychopharmacology in childhood, in Behavioral Science in Pediatric Medicine (N. B. Talbot, J. Kagan, and L. Eisenberg, eds.), pp. 397–424, W. B. Saunders, Philadelphia.Google Scholar
  91. Eisenberg, L., Gilbert, A., Cytryn, L., and Molling, P. A., 1961, The effectiveness of psychotherapy alone and in conjunction with perphenazine or placebo in the treatment of neurotic and hyperkinetic children, Am. J. Psychiat. 117:1088–1093.PubMedGoogle Scholar
  92. Engelhardt, D. M., 1973, Outpatient pediatric psychopharmacology, Psychopharm. Bull., Spec. Issue: Pharmacotherapy of Children, pp. 11-13.Google Scholar
  93. Engelhardt, D. M., Polizos, P., and Margolis, R., 1972, The drug treatment of childhood psychosis, in Drugs, Development and Cerebral Function (W. L. Smith, ed.), Charles Thomas, Springfield, Illinois.Google Scholar
  94. Engelhardt, D. M., Polizos, P., Waizer, J., and Hoffman, S. P., 1973, A double-blind comparison of Fluphenazine and Haloperidol in outpatient schizophrenic children, J. Aut. Child. Schiz. 3:128–137.Google Scholar
  95. Engelhardt, D. M., Polizos, P., and Waizer, J., 1975, CNS consequences of psychotropic drug withdrawal in autistic children: A follow-up report, Psychopharm. Bull. 11 (Jan.):6–7.Google Scholar
  96. Epstein, L. C., Lasagna, L., Conners, C. K., and Rodriguez, A., 1968, Correlation of dextroamphetamine excretion and drug response in hyperkinetic children, J. Nerv. Mental Dis. 146:136–146.Google Scholar
  97. Essman, W. B., 1971, Drug effects and learning and memory processes, Adv. Pharmacol. Chemother. 9:241–330.PubMedGoogle Scholar
  98. Eveloff, H. H., 1970, Pediatrie psychopharmacology, in Principles of Psychopharmacology (W. G. Clark and J. del Guidice, eds.), pp. 683–694, Academic Press, New York.Google Scholar
  99. Feingold, B., 1974, Why Your Child is Hyperactive, Random House, New York.Google Scholar
  100. Finnerty, R. J., Soltys, J. J., and Cole, J. O., 1971, The use of D-amphetamine with hyperkinetic children, Psycopharmacologia 21:302–308.Google Scholar
  101. Fish, B., 1960, Drug therapy in child psychiatry: Pharmacological aspects, Comp. Psychiat. 1:212–227.Google Scholar
  102. Fish, B., 1971, The “one child one drug” myth of stimulants in hyperkinesis, Arch. Gen. Psychiat. 25:193–203.Google Scholar
  103. Fish, B., 1973, Summary report of the children’s psychopharmacology unit at NYU Medical Center, Psychopharm. Bull., Spec. Issue, Pharmacotherapy of Children, pp. 13-18.Google Scholar
  104. Fish, B., Shapiro, T., and Campbell, M., 1966, Long-term prognosis and the response of schizophrenic children to drug therapy: A controlled study of trifluperazine, Am. J. Psychiat. 123:32–39.PubMedGoogle Scholar
  105. Fish, B., Campbell, M., Shapiro, T., and Floyd, A., 1969, Schizophrenic children treated with methysergide (Sansert), Dis. Nerv. Syst. 30:534–540.PubMedGoogle Scholar
  106. Fisher, C., Kahn, E., Edwards, A., and Davis, D. M., 1973, A psychophysiological study of nightmares and night terrors: The suppression of stage 4 night terrors with Diazepam, Arch. Gen. Psychiat. 28:252–259.PubMedGoogle Scholar
  107. Forrester, R. M., Stein, A., and Susser, M. W., 1964, A trial of conditioning therapy in nocturnal enuresis, Dev. Med. Child Nenrol. 6:158–166.Google Scholar
  108. Forsythe, W. I., and Redmond, A., 1974, Enuresis and spontaneous cure rate: A study of 1129 enuretics, Arch. Dis. Child. 49:259–263.PubMedGoogle Scholar
  109. Foster, J. C., and Anderson, J. E., 1936, Unpleasant dreams in childhood, Child Dev. 7:77–84.Google Scholar
  110. Frederiks, J. A., 1970, Facial tics in children: The therapeutic effect of low-dosage Diazepam, Br. J. Clin. Pract. 24:17–20.PubMedGoogle Scholar
  111. Freed, H., and Peifer, C. A., 1956, Treatment of hyperkinetic emotionally disturbed children with prolonged administration of Chlorpromazine, Am. J. Psychiat. 113:22–26.PubMedGoogle Scholar
  112. Freedman, A. M., Effron, A. S., and Bender, L., 1955, Pharmacotherapy in children with psychiatric illness, J. Nerv. Mental Dis. 122:479–486.Google Scholar
  113. Freedman, A. M., Deutsch, M., and Deutsch, C. P., 1960, Effects of hydroxyzine hydrochloride on the reaction time performance of schizophrenic children, Arch. Gen. Psychiat. 3:153–159.PubMedGoogle Scholar
  114. Freeman, R. D., 1966, Drug effects on learning in children: A selective review of the past thirty years, J. Spec. Ed. 1:17–44.Google Scholar
  115. Freeman, R. D., 1970, Psychopharmacology and the retarded child, in Psychiatric Approaches to Mental Retardation (F. Menolascino, ed.), pp. 294–368, Basic Books, New York.Google Scholar
  116. Frommer, E. A., 1967, Treatment of childhood depression with antidepressant drugs, Br. Med. J. 1:729–732.PubMedGoogle Scholar
  117. Gabourie, J., Becker, J. W., and Bateman, B., 1975, Oral dimethyl sulfoxide in mental retardation. Part I. Preliminary behavioral and psychometric data, Ann. N. Y. Acad. Sci. 243:449–459.PubMedGoogle Scholar
  118. Gardner, W. I., 1971, Behavior Modification in Mental Retardation, Aldine-Atherton, Chicago.Google Scholar
  119. Gestaut, H., Roger, J., and Lob, H., 1973, Medical treatment of epilepsy, in Anticonvulsant Drugs, Vol. 2 (J. Mercier, ed.), pp. 535–598, Pergamon Press, Oxford.Google Scholar
  120. Giller, A., and Bernadou, M., 1975, Dimethyl sulfoxide therapy in nonmongoloid infantile oligophrenia, Ann. N. Y. Acad. Sci. 243:432–448.PubMedGoogle Scholar
  121. Gittelman-Klein, R., 1975, Pharmacotherapy and management of pathological separation anxiety, Int. J. Ment. Health 4:255–271.Google Scholar
  122. Gittelman-Klein, R., and Klein, D. F., 1971, Controlled Imipramine treatment of school phobia, Arch. Gen. Psychiat. 25:204–207.Google Scholar
  123. Gittelman-Klein, R., and Klein, D., 1973, Methylphenidate effects in learning disability in children, Paper read at the 126th Annual Meeting of the Am. Psychiat. Assoc., Honolulu (May).Google Scholar
  124. Gittelman-Klein, R., Klein, D. F., Flexibrod, J., Abikoff, H., Katz, S., Gloisten, A., Kates, W., and Saraf, K., 1975, Methylphenidate vs. behavior therapy in hyperkinetic children, Paper presented at the Annual Meeting of the Amer. Psychiat. Assoc., Anaheim, California (May).Google Scholar
  125. Glaser, K., 1959, School phobia and related conditions, Pediatrics 23:371–383.PubMedGoogle Scholar
  126. Glick, B. S., Schulman, D., and Turecki, S., 1971, Diazepam (Valium) treatment in childhood sleep disorders, Dis. Nerv. Syst. 32:565–566.PubMedGoogle Scholar
  127. Goldfarb, W., 1970, Childhood psychosis, in Manual of Child Psychology, 3rd ed. (P. H. Mussen, ed.), pp. 765–803, Wiley, New York.Google Scholar
  128. Goldman, R., 1966, The use of Mellaril as an adjunct in the treatment of stuttering, Excerpta Medica Int. Congr. Ser. No. 150 (Proc. IV World Congr. Psychiatry).Google Scholar
  129. Graham, P., 1973, Depth of sleep and enuresis: A critical review, Clin. Dev. Med. 48/49:78–83.Google Scholar
  130. Graham, B. D., Rosenblum, S., and Callahan, R. J., 1958, Placebo-controlled study of reserpine in maladjusted retarded children, AMA J. Dis. Child. 96:690–695.PubMedGoogle Scholar
  131. Gram, L. F., and Rafaelsen, O. J., 1972, Lithium treatment of psychotic children and adolescents, Acta Psychiat. Scand. 48:253–260.PubMedGoogle Scholar
  132. Grant, Q. R., 1962, Psychopharmacology in childhood emotional and mental disorders, Pediatrics 61:626–637.Google Scholar
  133. Grant, R. H., 1974, Sulthiame and behaviour, Dev. Med. Child. Neurol. 16:821–823.PubMedGoogle Scholar
  134. Green, J. R., Troupin, A. S., Halpern, L. M., Friel, P., and Kanarek, P., 1974, Sulthiame: Evaluation as an anticonvulsant, Epilepsia 15:329–349.PubMedGoogle Scholar
  135. Greenbaum, G. C., 1970, An evaluation of niacinamide in the treatment of childhood schizophrenia, Am. J. Psychiat. 127:89–92.PubMedGoogle Scholar
  136. Greenberg, L. M., and Lourie, R. S., 1972, Physiochemical treatment methods, in Manual of Child Psychopathology (B. B. Wolman, ed.), pp. 1010–1031, McGraw-Hill, New York.Google Scholar
  137. Greenberg, L. M., Deem, M. A., and McMahon, S., 1972, Effects of dextroamphetamine, chlorpromazine, and hydroxyzine on behavior and performance in hyperactive children, Am. J. Psychiat. 129:532–539.PubMedGoogle Scholar
  138. Greenhill, L. L., Rieder, R. O., Wender, P. H., Buchsbaum, M., and Zahn, T. P., 1973, Lithium carbonate in the treatment of hyperactive children, Arch. Gen. Psychiat. 28:636–640.PubMedGoogle Scholar
  139. Griffiths, A. W., 1970, Drug trials, in Mental Subnormality: Modern Trends in Research (B. W. Richards, ed.), pp. 164–202, Pitman Medical and Scientific Publ. Co., London.Google Scholar
  140. Gross, M. D., 1973, Imipramine in the treatment of minimal brain dysfunction in children, Psychosomatics 14:283–285.PubMedGoogle Scholar
  141. Gross, M. D., and Wilson, W. C., 1974, Minimal Brain Dysfunction, Brunner/Mazel, New York.Google Scholar
  142. Guey, J., Charles, C., Coquery, C., Roger, J., and Soulayrol, R., 1967, Study of psychological effects of ethosuximide (Zarontin) on 25 children suffering from petit mal epilepsy, Epilepsia 8:129–141.Google Scholar
  143. Hackett, J. D., Hoffman, M., Macloed, A. S., and Surtees, R., 1958, A study of the effects of chlorpromazine as an aid to therapy for stuttering with a one year follow-up, Paper presented at the Amer. Speech and Hearing Assoc. Annual Convention in New York.Google Scholar
  144. Harrington, M., 1960, Phenmetrazine in the treatment of nocturnal enuresis, Practitioner 185:343–346.PubMedGoogle Scholar
  145. Hartlage, L. C., 1965, Effects of chlorpromazine on learning, Psych. Bull. 64:235–245.Google Scholar
  146. Healy, C. E., 1974, Possible remedy for stuttering, Pediatrics 53:587–588.PubMedGoogle Scholar
  147. Heaton-Ward, W. A., and Jancar, J., 1958, A controlled clinical trial of meprobamate in the management of difficult and destructive female mental defectives, J. Mental Sci. 104:454–456.Google Scholar
  148. Helper, M. M., Wilcott, R. C., and Garfield, S. L., 1963, Effects of chlorpromazine on learning and related processes in emotionally disturbed children, J. Consult. Psych. 27:1–9.Google Scholar
  149. Herjanic, B. M., and Penick, E. C., 1972, Adult outcome of disabled child readers, J. Spec. Ed. 6:397–410.Google Scholar
  150. Hersov, L. A., 1960, Refusal to go to school, J. Child Psych. Psychiat. 1:137–145.Google Scholar
  151. Hewett, F. M., Taylor, F. D., and Artuso, A. A., 1969, The Santa Monica project: Evaluation of an engineered classroom design with emotionally disturbed children, Except. Child, 35:523–529.PubMedGoogle Scholar
  152. Holdsworth, L., and Whitmore, K., 1974, A study of children with epilepsy attending ordinary schools. 1. Their seizure patterns, progress, and behaviour in school, Develop. Med. Child. Neurol. 16:746–758.PubMedGoogle Scholar
  153. Horwitz, F. D., and Paden, L. Y., 1973, The effectiveness of environmental intervention programs, in Review of Child Development Research, Vol. III (B. M. Caldwell and H. N. Ricciuti, eds.), pp. 331–402, Univ. of Chicago Press, Chicago.Google Scholar
  154. Huestis, R., Arnold, L. E., and Smeltzer, D., 1975, Caffeine versus methylphenidate and d-amphetamine in minimal brain dysfunction: A double blind comparison, Am. J. Psychiat. 132:868–870.PubMedGoogle Scholar
  155. Hunter, H., and Stephenson, G. M., 1963, Chlorpromazine and trifluperazine in the treatment of behavioural abnormalities in the severely subnormal child, Br. J. Psychiat. 109:411–417.Google Scholar
  156. Hutt, C., Jackson, P. M., and Level, M., 1966, Behavioural parameters and drug effects: A study of a hyperkinetic epileptic child, Epilepsia 7:250–259.PubMedGoogle Scholar
  157. Hutt, S. J., and Hutt, C., 1964, Hyperactivity in a group of epileptic (and some non-epileptic) brain-damaged children, Epilepsia 5:334–351.PubMedGoogle Scholar
  158. Iivanainen, M., 1974, A study of the origins of mental retardation, Clin. Dev. Med. 51:39.Google Scholar
  159. Ingram, T. T., 1956, A characteristic form of overactive behaviour in brain damaged children, J. Mental Sci. 102:550–558.Google Scholar
  160. Irwin, S., 1974, The uses and relative hazard potential of psychoactive drugs, Bull. Menninger Clin. 38:14–48.PubMedGoogle Scholar
  161. Ison, M. G., 1957, The effect of “Thorazine” on Wechsler scores, Am. J. Mental Def. 62:543–547.Google Scholar
  162. Itil, T. M., and Myers, J. P., 1973, Epileptic and anti-epileptic properties of psychotropic drugs, in Anticonvulsant Drugs, Vol. 2 (J. Mercier, ed.), pp. 599–622, Pergamon Press, Oxford.Google Scholar
  163. Itil, T. M., Rizzo, A. E., and Shapiro, D. M., 1967, Study of behavior and EEG correlation during treatment of disturbed children, Dis. Nerv. Syst. 28:731–736.PubMedGoogle Scholar
  164. Jarvik, M. E., 1969, Effects of drugs on memory, in Drugs and the Brain (P. Black, ed.), pp. 135–146, Johns Hopkins Press, Baltimore.Google Scholar
  165. Jencks, C., 1972, Inequality: A Reassessment of the Effect of Family and Schooling in America, Basic Books, New York.Google Scholar
  166. Jenkins, R. L., and Stable, G., 1971, Special characteristics of retarded children rated as severely hyperactive, Child Psychiat. Hum. Dev. 2:26–31.Google Scholar
  167. Johnson, A. M., 1957, School phobia workshop, 1955. 3. Discussion, Am. J. Orthopsychiat. 27:307–309.PubMedGoogle Scholar
  168. Kahn, J. H., and Nursten, J. P., 1962, School refusal: A comprehensive view of school phobia and other failures of school attendance, Am. J. Orthopsychiat. 32:707–718.PubMedGoogle Scholar
  169. Kay, D. W., and Leigh, D., 1954, The natural history, treatment and prognosis of anorexia nervosa, based on a study of 38 patients, J. Mental Sci. 100:411–431.Google Scholar
  170. Kelly, D., Guirguis, W., Frommer, E., Mitchell-Heggs, N., and Sargant, W., 1970, Treatment of phobic states with antidepressants; a retrospective study of 246 patients, Br. J. Psychiat. 116:387–398.Google Scholar
  171. Kelman, D. H., 1965, Gilles de la Tourette’s disease in children, a review of the literature, J. Child Psych. Psychiat. 6:219–226.Google Scholar
  172. Kennedy, W. A., 1965, School phobia: Rapid treatment of fifty cases, J. Abn. Psych. 70:285–289.Google Scholar
  173. Kenny, T. J., Badie, D., and Baldwin, R. W., 1968, The effectiveness of a new drug, Mesoridazine, and chlorpromazine with behavior problems in children, J. Nerv. Mental Dis. 147:316–321.Google Scholar
  174. Kirman, B., 1975, Drug therapy in mental handicap, Br. J. Psychiat. 127:545–549.Google Scholar
  175. Klein, D. F., 1964, Delineation of two drug-responsive anxiety syndromes, Psychopharmacologia 5:397–408.PubMedGoogle Scholar
  176. Kneebone, G. M., 1968, The use of sulthiame (“Ospolot”) in the epileptic child with the hyperkinetic syndrome, Med. J. Aust. 2:1096–1097.PubMedGoogle Scholar
  177. Knights, R. M., and Hinton, G. G., 1969, The effects of methylphenidate (Ritalin) on the motor skills and behavior of children with learning problems, J. Nerv. Mental Dis. 148:643–653.Google Scholar
  178. Kornetsky, C., 1975, Minimal brain dysfunction and drugs, in Perceptual and Learning Disabilities in Children Vol. 2 (W. M. Cruickshank and D. P. Hallahan, eds.), pp. 447–481, Syracuse Univ. Press, Syracuse, New York.Google Scholar
  179. Kraft, I. A., Marcus, I. M., Wilson, W., Swander, D. V., Rumage, N. S., and Schulhofer, E., 1959, Methodological problems in studying the effect of tranquilizers in children with specific reference to Meprobamate, South. Med. J. 52:179–185.PubMedGoogle Scholar
  180. Krager, J. M., and Safer, D. J., 1974, Type and prevalence of medication used in the treatment of hyperactive children, New Eng. J. Med. 291:1118–1120.PubMedGoogle Scholar
  181. Kugel, R. B., and Parsons, M. H., 1967, Children of Deprivation: Changing the Course of Familial Retardation: U. S. Dept. of HEW, Children’s Bureau, Washington, D. C.Google Scholar
  182. Lapouse, R., and Monk, M. A., 1958, An epidemiologic study of behavior characteristics in children, Am. J. Public Health 48:1134–1144.Google Scholar
  183. La Veck, G. D., and Buckley, P., 1961, The use of psychopharmacologic agents in retarded children with behavior disorders, J. Chron. Dis. 13:174–183.Google Scholar
  184. Lazarus, A. A., Davison, G. C., and Polefka, D. A., 1965, Classical and operant factors in the treatment of a school phobia, J. Abn. Psych. 70:225–229.Google Scholar
  185. Le Vann, L. J., 1962, Chlordiazopoxide, a tranquilizer with anticonvulsant properties, Canad. Med. Assoc. J. 86:123–125.Google Scholar
  186. Le Vann, L. J., 1970, Clinical experience with Tarasan and Thioridazine in mentally retarded children: A comparative double blind study, Appl. Ther. 12 (May):30–33.Google Scholar
  187. Le Vann, L. J., 1971, Clinical comparison of haloperidol with chlorpromazine in mentally retarded children, Am. J. Mental Def. 75:719–723.Google Scholar
  188. Lindsley, D. B., and Henry, C. E., 1942, The effect of drugs on behavior and the electroencephalograms of children with behavior disorders, Psychosom. Med. 4:140–149.Google Scholar
  189. Lipman, R. S., 1970, The use of psychopharmacological agents in residential facilities for the retarded, in Psychiatric Approaches to Mental Retardation (F. J. Menolascino, ed.), pp. 387–398, Basic Books, New York.Google Scholar
  190. Lipsedge, M. S., Hajioff, J., Huggins, P., Napier, L., Pearce, J., Pike, D. J., and Rich, M., 1973, The management of severe agoraphobia: A comparison of Iproniazid and systematic desensitization, Psychopharmacologia 32:67–80.PubMedGoogle Scholar
  191. Livingston, S., Kajdi, L., and Bridge, E. M., 1948, The use of benzedrine and dexedrine sulfate in the treatment of epilepsy, J. Pediat. 32:490–494.PubMedGoogle Scholar
  192. Livingston, S., Pauli, L. L., and Berman, W., 1974, Carbamazepine (Tegretol) in epilepsy, Dis. Nerv. Syst. 35:103–107.PubMedGoogle Scholar
  193. Louttit, R. T., 1965, Chemical facilitation of intelligence among the mentally retarded, Am. J. Mental Def. 69:495–501.Google Scholar
  194. Lucas, A. R., 1964, Gilles de la Tourette’s disease in children: Treatment with phenothiazine drugs, Am. J. Psychiat. 121:606–608.PubMedGoogle Scholar
  195. Lucas, A. R., and Pasley, F. C., 1969, Psychoactive drugs in the treatment of emotionally disturbed children: Haloperidol and Diazepam, Comp. Psychiat. 10:376–386.Google Scholar
  196. Macfarlane, J. W., Allen, L., and Honzik, M. P., 1954, A Developmental Study of the Behavior Problems of Normal Children between Twenty-One Months and Fourteen Years, Univ. of California Press, Berkeley, California.Google Scholar
  197. Mack, J., 1970, Nightmares and Human Conflict, Little, Brown, Boston.Google Scholar
  198. MacLean, R. E., 1960, Imipramine hydrochloride (Tofranil) and enuresis, Am. J. Psychiat. 117:551.PubMedGoogle Scholar
  199. Matti, N., Viukari, A., and Tammisto, P., 1969, Central effects of diphenylhydantoin (Dilantin) in epileptic oligophrenics during phenobarbital-primidone withdrawal, sodium bicarbonate, and ammonium chloride administration, Behav. Neuropsychiat. 1:13–16.Google Scholar
  200. Maxmen, J. S., Silberfarb, P. M., and Ferrell, R. B., 1974, Anorexia nervosa: Practical initial management in a general hospital, JAMA 229:801–803.PubMedGoogle Scholar
  201. May, P. R., 1968, Treatment of Schizophrenia: A Comparative Study of Five Treatment Methods, Science House, New York.Google Scholar
  202. McAndrew, J. B., Case, Q., and Treffert, D. A., 1972, Effects of prolonged phenothiazine intake on psychotic and other hospitalized children, J. Aut. Child. Schiz. 2:75–91.Google Scholar
  203. McConaghy, N., 1969, A controlled trial of imipramine, amphetamine, pad-and-bell conditioning and random awakening in the treatment of nocturnal enuresis, Med. J. Aust. 2:237–239.PubMedGoogle Scholar
  204. McGaugh, J. L., 1969, Effects of analeptics on learning and memory in infrahumans, in Drugs and the Brain (P. Black, ed.), pp. 241–250, Johns Hopkins Univ. Press, Baltimore.Google Scholar
  205. McKendry, J. B., and Stewart, D. A., 1974, Enuresis, Ped. Clin. N. Am. 21:1019–1028.Google Scholar
  206. Meadow, R., 1974, Drugs for bed-wetting, Arch. Dis. Child. 49:257–258.PubMedGoogle Scholar
  207. Mendelson, W., Johnson, N., and Stewart, M. A., 1971, Hyperactive children as teenagers: A follow-up study, J. Nerv. Mental Dis. 153:273–279.Google Scholar
  208. Menolascino, F. J., 1965, Emotional disturbance and mental retardation, Am. J. Mental Def. 70:248–256.Google Scholar
  209. Menolascino, F. J., 1969, Emotional disturbances in mentally retarded children, Am. J. Psychiat. 126:168–176.PubMedGoogle Scholar
  210. Millichap, J. G., 1969, Management of hyperkinetic behavior in children with epilepsy, in Treatment of Epilepsy and Other Paroxysmal Disorders (J. G. Millichap, ed.), Hoebner, New York.Google Scholar
  211. Millichap, J. G., and Fowler, G. W., 1967, Treatment of “minimal brain dysfunction” syndromes, Ped. Clin. N. Am. 14:767–777.Google Scholar
  212. Millichap, J. G., Aymat, F., Sturgis, L. H., Larsen, K. W., and Egan, R. A., 1968, Hyperkinetic behavior and learning disorders III. Battery of neuropsychological tests in controlled test of methylphenidate, Am. J. Dis. Child. 116:235–244.PubMedGoogle Scholar
  213. Milman, D. H., 1974, Haloperidol in stuttering, Pediatrics 54:660.Google Scholar
  214. Mirsky, A. F., and Rosvold, H. E., 1960, The use of psychoactive drugs as a neuropsychological tool in studies of attention in man, in Drugs and Behavior (L. Uhr and J. G. Miller, eds.), pp. 375–392, Wiley, New York.Google Scholar
  215. Mitchell, A. C., Hargis, C. H., McCarry, F., and Powers, C., 1959, Effects of prochlorperazine therapy on educability in disturbed mentally retarded adolescents, Am. J. Mental Def. 64:57–62.Google Scholar
  216. Moffatt, W. R., Siddiqui, A. R., and MacKay, D. N., 1970, The use of sulthiame with disturbed mentally subnormal patients, Br. J. Psychiat. 117:673–678.Google Scholar
  217. Molitch, M., and Eccles, A. K., 1937, The effect of benzedrine sulfate on the intelligence scores of children, Am. J. Psychiat. 94:588–590.Google Scholar
  218. Molitch, M., and Sullivan, J. P., 1937, The effect of benzedrine sulfate on children taking the new Stanford Binet Achievement Test, Am. J. Orthopsychiat. 7:519–522.Google Scholar
  219. Moore, B. C., Thuline, H. C., and Capes, L., 1968, Mongoloid and nonmongoloid retardates: A behavioral comparison, Am. J. Mental Def. 73:433–436.Google Scholar
  220. Morgan, H., and Russell, G., 1975, Value of family background and clinical features as predictors of long-term outcome in anorexia nervosa: Four-year follow-up study of 41 patients, Psych. Med. 5:355–391.Google Scholar
  221. Morgar, R. E., and Aldrich, R. W., 1969, The use of psychedelic agents with autistic schizophrenic children, Behav. Neuropsychiat. 1 (Nov.):44–52.Google Scholar
  222. Mykelbust, H. R., and Boshes, B., 1969, Minimal Brain Damage in Children, U.S. Dept. of HEW, Washington, D.C.Google Scholar
  223. Nellhaus, G., 1974, Management of seizure disorders in infancy, childhood and adolescence, in Drugs and the Developing Brain (A. Vernadakis and N. Wiener, eds.), pp. 503–520, Plenum Press, New York.Google Scholar
  224. Nihira, K., 1973, Importance of environmental demands in the measurement of adaptive behavior, in Sociobehavioral Studies in Mental Retardation (G. Tarjan, R. K. Eyman and C. E. Meyers, eds.), pp. 101–116, Am. Assoc. Ment. Defic., Los Angeles, California.Google Scholar
  225. O’Leary, S. G., and O’Leary, K. D., 1976, Behavior modification in the school, in Handbook of Behavior Modification and Behavior Therapy (H. Leitenberg, ed.), Prentice-Hall, Englewood Cliffs, New Jersey.Google Scholar
  226. O’Leary, K. D., Pelham, W. E., Rosenbaum, A., and Price, G. H., 1976, Behavioral treatment of hyperkinetic children: An experimental evaluation of its usefulness, Clin. Pediat. 15:510–515.PubMedGoogle Scholar
  227. Owen, J. D., 1971, The effects of chlorpromazine on performance of schizophrenic patients on two tests for brain damage and related measures, Dis. Abstr. Inter. 31:7B, 4343B (Jan.).Google Scholar
  228. Page, J. G., Janicki, R. S., Bernstein, J. E., Curran, C. F., and Michelli, F. A., 1974, Pemoline (Cylert) in the treatment of childhood hyperkinesis, J. Learn. Disabil. 7:498–503.Google Scholar
  229. Pallister, P. D., and Stevens, R. R., 1957, Effects of Serpasil in small dosage on behavior, intelligence, and physiology, Am. J. Mental Def. 62:267–274.Google Scholar
  230. Parel, J. M., Black, N., Wharton, R. H., and Malitz, S., 1969, Inhibition of imipramine metabolism by methylphenidate, Fed. Proc. 28:418.Google Scholar
  231. Pauig, P. M., Deluca, M. A., and Osterheld, R. G., 1961, Thioridazine hydrochloride in the treatment of behavior disorders in epileptics, Am. J. Psychiat. 117:832–833.PubMedGoogle Scholar
  232. Paulson, G. W., and Buffaloe, W. J., 1964, Clinical note: Use of thioridazine hydrochloride in epilepsy, Dis. Nerv. Syst. 25:243.PubMedGoogle Scholar
  233. Paulson, G. W., Rizvi, C. A., and Crane, G. E., 1975, Tardive dyskinesia as a possible sequel of long-term therapy with phenothiazines, Clin. Pediat. 14:953–955.PubMedGoogle Scholar
  234. Pesikoff, R. B., 1973, Therapy for pavor nocturnus and somnambulism, Curr. Psychiat. Ther. 13:63–66.Google Scholar
  235. Pesikoff, R. B., and Davis, P. C., 1971, Treatment of pavor nocturnus and somnambulism in children, Am. J. Psychiat. 128:778–781.PubMedGoogle Scholar
  236. Petersen, K. E., Andersen, O. O., Hansen, T., 1974, Mode of action and relative value of imipramine and similar drugs in the treatment of nocturnal enuresis, Eur. J. Clin. Pharmacol. 7:187–194.PubMedGoogle Scholar
  237. Petti, T. A., and Campbell, M., 1975, Imipramine and seizures, Am. J. Psychiat. 132:538–540.PubMedGoogle Scholar
  238. Pilkington, T. L., 1961, Comparative effects of Librium and Taractan on behavior disorders of mentally retarded children, Dis. Nerv. Syst. 22:573–575.PubMedGoogle Scholar
  239. Pilkington, T. L., 1962, A report on “Tofranil” in mental deficiency, Am. J. Mental Def. 66:729–732.Google Scholar
  240. Pinkerton, P., 1975, Childhood Disorders—A Psychosomatic Approach, Columbia Univ. Press, New York.Google Scholar
  241. Polizos, P., Engelhardt, D. M., Hoffman, S. P., and Waizer, J., 1973, Neurological consequences of psychotropic drug withdrawal in schizophrenic children, J. Aut. Child. Schiz. 3:247–253.Google Scholar
  242. Pollack, M., 1970, Chlorpromazine and CNS changes in man, in Drugs and Cerebral Function (W. L. Smith, ed.), pp. 41–52, Charles Thomas, Springfield, Illinois.Google Scholar
  243. Poussaint, A. F., Ditman, K. S., and Greenfield, R., 1966, Amitryptiline in childhood enuresis, Clin. Pharm. Ther. 7:21–25.Google Scholar
  244. Pregelj, S., and Barkauskas, A., 1967, Thioridiazine in the treatment of mentally retarded children, Canad. Psychiat. Assoc. J. 12:213–215.Google Scholar
  245. Quinn, P. O., and Rapoport, J. L., 1975, One-year follow-up of hyperactive boys treated with imipramine or methylphenidate, Am. J. Psychiat. 132:241–245.PubMedGoogle Scholar
  246. Quinn, P. T., and Peachey, E. C., 1973, Haloperidol in the treatment of stutterers, Br. J. Psychiat. 123:247–248.Google Scholar
  247. Rabiner, C. J., and Klein, D. F., 1969, Imipramine treatment of school phobia, Comp. Psychiat. 10:387–390.Google Scholar
  248. Rapoport, J. L., Quinn, P. O., Bradbard, G., Riddle, D., and Brooks, E., 1974, Imipramine and methylphenidate treatments of hyperactive boys, Arch. Gen. Psychiat. 30:789–793.PubMedGoogle Scholar
  249. Rawitt, K. C., 1959, The usefulness of effectiveness of Equanil in children, Am. J. Psychiat. 115:1120–1121.PubMedGoogle Scholar
  250. Renshaw, D. C., 1975, Psychopharmacology in children, in Rational Psychopharmacology and the Right to Treatment (F. J. Ayd, ed.), pp. 131–150, Ayd Med. Communications Ltd., Baltimore.Google Scholar
  251. Rettig, J. A., 1956, Chlorpromazine and mysoline in the control of convulsive epilepsy in mentally deficient patients, J. Nerv. Mental Dis. 124:607–611.Google Scholar
  252. Rie, H. E., 1975, Hyperactivity in children, Am. J. Dis. Child. 129:783–789.PubMedGoogle Scholar
  253. Ritvo, E. R., Ornitz, E. M., Gottlieb, F., Poussaint, A. F., Maron, B. J., Ditman, K. S., and Blinn, K. A., 1969, Arousal and nonarousal enuretic events, Am. J. Psychiat. 126:77–84.PubMedGoogle Scholar
  254. Ritvo, E. R., Yuwiler, A., Geller, E., Kales, A., Rashkis, S., Schicor, A., Plotkin, S., Axelrod, R., and Howard, C., 1971, Effects of L-dopa in autism, J. Aut. Child. Schiz. 1:190–205.Google Scholar
  255. Rodin, E. A., Rim, C. S., and Rennick, P. M., 1974, The effects of carbamazepine on patients with psychomotor epilepsy: Results of a double-blind study, Epilepsia 15:547–561.PubMedGoogle Scholar
  256. Rodriguez, A., Rodriguez, M., and Eisenberg, L., 1959, The outcome of school phobia: A follow-up study based on 41 cases, Am. J. Psychiat. 116;540–544.Google Scholar
  257. Rosenberger, P. B., Wheelden, J. A., and Kalotkin, M., 1976, The effect of haloperidol on stuttering, Am. J. Psychiat. 133:331–334.PubMedGoogle Scholar
  258. Rudy, L. H., Himwich, H. E., and Rinaldi, F., 1958, A clinical evaluation of psychopharmacological agents in the management of disturbed mentally defective patients, Am. J. Mental Def. 62:855–860.Google Scholar
  259. Russell, G. F., 1970, Anorexia nervosa: Its identity as an illness and its treatment, Mod. Trends Psych. Med. 2:131–164.Google Scholar
  260. Rutter, M., 1965, The influence of organic and emotional factors on the origins, nature and outcome of childhood psychosis, Dev. Med. Child Nenrol. 7:518–528.Google Scholar
  261. Rutter, M. L., 1971, Psychiatry, in Mental Retardation: An Annual Review, Vol. III (J. Wortis, ed.), pp. 186–221, Grune and Stratton, New York.Google Scholar
  262. Rutter, M., Graham, P., and Yule, W., 1970a, A Neuropsychiatric Study in Childhood, Lippincott, Philadelphia.Google Scholar
  263. Rutter, M. L., Tizard, J., and Whitmore, K., 1970b, Education, Health and Behaviour, Wiley, New York.Google Scholar
  264. Rutter, M., Yule, W., and Graham, P., 1973, Enuresis and behaviour deviance: Some epidemiological considerations, Clin. Dev. Med. 48/49:137–147.Google Scholar
  265. Sabot, L. M., Peck, R., and Raskin, J., 1969, The waiting room society: A study of families and children applying to a child psychiatric clinic, Arch. Gen. Psychiat. 21:25–32.PubMedGoogle Scholar
  266. Safer, D. J., and Allen, R. P., 1975a, Side effects from long-term use of stimulants in children, Int. J. Mental Health 4:105–118.Google Scholar
  267. Safer, D. J., and Allen, R. P., 1975b, Stimulant drug treatment of hyperactive adolescents, Dis. Nerv. Syst. 36:454–457.PubMedGoogle Scholar
  268. Safer, D. J., and Allen, R. P., 1976, Hyperactive Children: Diagnosis and Management, University Park Press, Baltimore.Google Scholar
  269. Safer, D. J., Allen, R. P., Calabria, R., Rodriguez, A., and Graham, R., 1972, Laboratory Correlates of Methylphenidate in Hyperactive Children, unpublished manuscript.Google Scholar
  270. Safer, D. J., Allen, R. P., and Barr, E., 1975, Growth rebound after termination of stimulant drugs, J. Pediat. 86:113–116.PubMedGoogle Scholar
  271. Saletu, B., Simeon, J., Saletu, M., Itil, T. M., and Da Silva, J., 1974, Behavioral and visual evoked potential investigations during trihexyphenidyl and thiothixene treatment in psychotic boys, Biol. Psychiat. 8:177–189.PubMedGoogle Scholar
  272. Saletu, B., Saletu, M., Simeon, J., and Marasa, J., 1975a, Fluphenazine treatment in the psychotic child: Clinical-evoked potential correlations, Comp. Psychiat. 16:265–278.Google Scholar
  273. Saletu, B., Saletu, M., Simeon, J., Viamontes, G., and Itil, T. M., 1975b, Comparative symptomatological and evoked potential studies with d-amphetamine, thioridazine, and placebo in hyperkinetic children, Biol. Psychiat. 10:253–275.PubMedGoogle Scholar
  274. Salmon, M. A., 1973, The concept of day-time treatment for primary nocturnal enuresis, Clin. Dev. Med. 48/49:189–194.Google Scholar
  275. Saraf, K. R., Klein, D. F., Gittelman-Klein, R., and Groff, S., 1974, Imipramine side effects in children, Psychopharmacologia 37:265–274.PubMedGoogle Scholar
  276. Sargant, W., and Blackburn, J. M., 1936, The effect of benzedrine on intelligence scores, Lancet 2:1385–1387.Google Scholar
  277. Schleifer, M., Weiss, G., Cohen, N., Elman, M., Cvejic, H., and Kruger, E., 1975, Hyperactivity in preschoolers and the effect of methylphenidate, Am. J. Orthopsychiat. 45:38–50.PubMedGoogle Scholar
  278. Schnackenberg, R. C., 1973, Caffeine as a substitute for schedule II stimulants in hyperkinetic children, Am. J. Psychiat. 130:796–798.PubMedGoogle Scholar
  279. Serrano, A. C., and Forbis, O. L., 1973, Haloperidol for psychiatric disorders in childhood, Dis. Nerv. Syst. 34:226–231.PubMedGoogle Scholar
  280. Shaffer, D., Costello, A. J., and Hill, I. D., 1968, Control of enuresis with imipramine, Arch. Dis. Child. 43:665–671.PubMedGoogle Scholar
  281. Shapiro, A. K., Shapiro, E., and Wayne, H., 1973, Treatment of Tourette’s syndrome with haloperidol, review of 34 cases, Arch. Gen. Psychiat. 28:92–97.PubMedGoogle Scholar
  282. Sharpe, D. S., 1962, A controlled trial of trifluoperizine in the treatment of the mentally subnormal patient, J. Mental Sci. 108:220–224.Google Scholar
  283. Sheehan, J. G., and Martyn, M. M., 1970, Stuttering and its disappearance, J. Speech Hearing Res. 13:279–289.PubMedGoogle Scholar
  284. Shepherd, M., Oppenheim, B., and Mitchell, S., 1971, Childhood Behavior and Mental Health, Grune and Stratton, New York.Google Scholar
  285. Silberberg, N. E., Iverson, I., and Goins, J., 1973, Which remedial reading method looks best? J. Learn. Disabil. 6:547–556.Google Scholar
  286. Simeon, J., Utech, C., Simeon, S., and Itil, T. M., 1974a, Pediatric psychopharmacology outside the U.S.A., Dis. Nerv. Syst. 34 (July):37–47 (Section 2).Google Scholar
  287. Simeon, J., Saletu, B., Saletu, M., Itil, T. M., and Da Silva, J., 1974b, Thiothixene in childhood psychoses, in Thiothixene and the Thioxanthenes (I. S. Forest, C. J. Carr, and E. Usdin, eds.), pp. 55–70, Raven Press, New York.Google Scholar
  288. Sleator, E. K., Von Neumann, A., and Sprague, R. L., 1974, Hyperactive children: A continuous long-term placebo-controlled follow-up, JAMA 229:316–317.PubMedGoogle Scholar
  289. Smith, W. L., Philippus, M. J., and Guard, H. L., 1968, Psychometric study of children with learning problems and 14-6 positive spike eeg patterns, treated with ethosuximide (Zarontin) and placebo, Arch. Dis. Child. 43:616–619.PubMedGoogle Scholar
  290. Snyder, S., and Meyerhoff, J., 1973, How amphetamine acts in minimal brain dysfunction, Ann. N. Y. Acad. Sci. 205:310–320.PubMedGoogle Scholar
  291. Somerfeld-Ziskind, E., and Ziskind, E., 1940, Effect of phenobarbital on the mentality of epileptic patients, AMA Arch. Neurol. Psychiat. 43:70–79.Google Scholar
  292. Spencer, D. A., 1970, Ronyl (Pemoline) in overactive mentally subnormal children, Br. J. Psychiat. 117:239–240.Google Scholar
  293. Sperling, M., 1971, Sleep disturbances in children, in Modern Perspectives in International Child Psychiatry (J. G. Howells, ed.), pp. 418–454, Brunner/Mazel, New York.Google Scholar
  294. Sprague, R. L., and Werry, J. S., 1971, Methodology of psychopharmacological studies with the retarded, in International Review of Research in Mental Retardation, Vol. V (N. R. Ellis, ed.), pp. 147–219, Academic Press, New York.Google Scholar
  295. Sprague, R. L., Barnes, K. R., and Werry, J. S., 1970, Methylphenidate and thioridazine: Learning, reaction time, activity and classroom behavior in disturbed children, Am. J. Orthopsychiat. 40:615–628.PubMedGoogle Scholar
  296. Sprogis, G. R., Lezdins, V., White, S. D., Ming, C., Lanning, M., Drake, M. E., and Wycoff, G., 1957, Comparative study of thorazine and serpasil in the mental defective, Am. J. Ment. Def. 61:737–742.Google Scholar
  297. Sroufe, L., 1975, Drug treatment of children with behavior problems, in Review of Child Development Research, Vol. IV (F. Horwitz, ed.), pp. 347–407, Univ. of Chicago Press, Chicago.Google Scholar
  298. Stack, J. J., 1972, Chemotherapy in childhood depression, in Depressive States in Childhood and Adolescence (A. Annell, ed.), pp. 460–466, Halstead Press, New York.Google Scholar
  299. Still, C., and Hans, C., 1973, Vesta variant of Tourette’s disease, South. Med. J. 66:1222–1225.PubMedGoogle Scholar
  300. Stores, G., 1975, Behavioural effects of anti-epileptic drugs, Dev. Med. Child Neurol. 17:647–658.PubMedGoogle Scholar
  301. Sunderland, J., Tait, H., and Eadie, M., 1974, The Epilepsies: Modern Diagnosis and Treatment, 2nd Ed., pp. 83–91, Churchill Livingston, Edinburgh.Google Scholar
  302. Swift, W. J., Swift, E. W., and Arellano, M., 1975, Haloperidol as a treatment for adult stuttering, Comp. Psychiat. 16:61–67.Google Scholar
  303. Tapia, F., 1969, Haldol in the treatment of children with tics and stutterers—and an incidental finding, Psychiat. Quart. 43:647–649.PubMedGoogle Scholar
  304. Tarjan, G., Wright, S. W., Eyman, R. K., and Keeran, C. V., 1973, Natural history of mental retardation: Some aspects of epidemiology, Am. J. Mental Def. 77:369–379.Google Scholar
  305. Tec, L., 1968, The treatment of enuresis with imipramine, Am. J. Psychiat. 125:266.PubMedGoogle Scholar
  306. Tec, L., 1971, Anorexia nervosa—follow-up on a special method of treatment, Am. J. Psychiat. 127:1702.PubMedGoogle Scholar
  307. Tec, L., 1974a, Nandrolone in anorexia nervosa, JAMA 228:1423.Google Scholar
  308. Tec, L., 1974b, Imipramine for nightmares, JAMA 228:978.PubMedGoogle Scholar
  309. Theander, S., 1970, Anorexia nervosa: A psychiatric investigation of 94 female patients, Acta Psychiat. Scand. Suppl. 214:5–194.Google Scholar
  310. Timberlake, W. H., Belmont, E. H., and Ogonik, J., 1957, The effect of reserpine in 200 mentally retarded children, Am. J. Mental Def. 62:61–66.Google Scholar
  311. Tizard, J., 1970, The role of social institutions in the causation, prevention and alleviation of mental retardation, in Socio-Cultural Aspects of Mental Retardation (H. C. Haywood, ed.), pp. 281–340, Appleton-Century-Crofts, New York.Google Scholar
  312. Troupin, A. S., Green, J. R., and Halpern, L. M., 1975, Carbamazepine (Tegretol) as an anti convulsant: A controlled double-blind comparison with diphenylhydantoin (Dilantin), Acta Neurol. Scand. Suppl. 60:13–26.PubMedGoogle Scholar
  313. Turner, R. K., 1973, Conditioning treatment of nocturnal enuresis: present status, Clin. Dev. Med. 48/49:195–210.Google Scholar
  314. Tyrer, P., Candy, J., and Kelly, D., 1973, Phenelzine in phobic anxiety: A controlled trial, Psych. Med. 3:120–1204.Google Scholar
  315. Ucer, E., and Kreger, K. C., 1969, A double-blind study comparing haloperidol with thioridazine in emotionally disturbed, mentally retarded children, Curr. Ther. Res. 11:278–283.PubMedGoogle Scholar
  316. Van Riper, C. G., 1971, The Nature of Stuttering, Prentice-Hall, Englewood Cliffs, New Jersey.Google Scholar
  317. Viukari, N., M., 1969, Diphenylhydantoin as an anticonvulsant: Evaluation of treatment in forty mentally subnormal epileptics, J. Mental Def. Res. 13:212–218.Google Scholar
  318. Waizer, J., Polizos, P., Hoffman, S. P., Engelhardt, D. M., and Margolis, R. A., 1972, A single-blind evaluation of thiothixene with outpatient schizophrenic children, J. Aut. Child. Schiz. 2:378–386.Google Scholar
  319. Waizer, J., Hoffman, S. P., Polizos, P., and Engelhardt, D. M., 1974, Outpatient treatment of hyperactive school children with imipramine, Am. J. Psychiat. 131:587–591.PubMedGoogle Scholar
  320. Waldfogel, S., Coolidge, J. C., and Hahn, P. B., 1957, The development, meaning and management of school phobia, Am. J. Orthopsychiat. 27:754–780.PubMedGoogle Scholar
  321. Waldfogel, S., Tessman, E., and Hahn, P. B., 1959, A program for early intervention in school phobia, Am. J. Orthopsychiat. 29:324–332.PubMedGoogle Scholar
  322. Wallace, I. R., and Forsythe, W. I., 1969, The treatment of enuresis: A controlled clinical trial of propantheline, propantheline-and-phenobarbitone and a placebo, Br. J. Clin. Pract. 23:207–210.PubMedGoogle Scholar
  323. Wapner, I., Thurston, D. L., and Holowach, J., 1962, Phenobarbital: Its effect on learning in epileptic children, JAMA 182:937.PubMedGoogle Scholar
  324. Weinberg, W. A., and Harwell, J. L., 1965, Diazepam (Valium) in myoclonic seizures, Am. J. Dis. Child. 109:123–127.PubMedGoogle Scholar
  325. Weiss, G., Werry, J., Minde, K., Douglas, V., and Sykes, D., 1968, Studies on the hyperactive child. V. The effects of dextroamphetamine and chlorpromazine on behaviour and intellectual functioning, J. Child Psych. Psychiat. 9:145–156.Google Scholar
  326. Weiss, G., Minde, K., Werry, J. S., Douglas, V., and Nemeth, E., 1971a, Studies on the hyperactive child. VIII. Five-year follow-up, Arch. Gen. Psychiat. 24:409–414.PubMedGoogle Scholar
  327. Weiss, G., Minde, K., Douglas, V., Werry, J., and Sykes, D., 1971b, Comparison of the effects of chlorpromazine, dextroamphetamine and methylphenidate on the behaviour and intellectual functioning of hyperactive children, Canad. Med. Assoc. J. 104:20–25.PubMedGoogle Scholar
  328. Weiss, G., Kruger, E., Danielson, U., and Elman, M., 1975, Effect of long-term treatment of hyperactive children with methylphenidate, Canad. Med. Assoc. J. 112:159–165.PubMedGoogle Scholar
  329. Wells, P. G., 1974, Haloperidol in the Treatment of Stutter, Med. J. Aust. 2:613.PubMedGoogle Scholar
  330. Wells, P. G., and Malcolm, M. T., 1971, Controlled Trial of the Treatment of 36 Stutterers, Br. J. Psychiat. 119:603–604.Google Scholar
  331. Werry, J. S., 1972a, Psychosomatic disorders, in Psychopathological Disorders of Childhood (H. C. Quay and J. S. Werry, eds.), pp. 122–172, Wiley, New York.Google Scholar
  332. Werry, J. S., 1972b, Childhood Psychosis, in Psychopathological Disorders of Childhood (H. C. Quay and J. S. Werry, eds.), pp. 173–233, Wiley, New York.Google Scholar
  333. Werry, J. S., and Aman, M. G., 1975, Methylphenidate and haloperidol in children: Effects on attention, memory, and activity, Arch. Gen. Psychiat. 32:790–795.PubMedGoogle Scholar
  334. Werry, J. S., and Bull, D., 1975, Anorexia nervosa: A case study using behavior therapy, J. Am. Acad. Child Psychiat. 14:646–651.Google Scholar
  335. Werry, J. S., and Cohrssen, J., 1965, Enuresis—An etiologic and therapeutic study, J. Pediat. 67:423–431.PubMedGoogle Scholar
  336. Werry, J. S., and Wollersheim, J. P., 1967, Behavior therapy with children: A broad overview, J. Am. Acad. Child Psychiat. 6:346–370.Google Scholar
  337. Werry, J. S., Weiss, G., Douglas, V., and Martin, J., 1966, Studies on the hyperactive child III. The effect of chlorpromazine upon behavior and learning ability, J. Am. Acad. Child Psychiat. 5:292–312.Google Scholar
  338. Werry, J. S., Dowrick, P. W., Lampen, E. L., and Vamos, M. J., 1975, Imipramine in enuresis—Psychological and physiological effects, J. Child Psych. Psychiat. 16:289–299.Google Scholar
  339. Whitehead, P. L., and Clark, L. D., 1970, Effect of lithium carbonate, placebo, and thioridazine on hyperactive children, Am. J. Psychiat. 127:824–825.PubMedGoogle Scholar
  340. Winsberg, B. G., Press, M., Bialer, I., and Kupietz, S., 1974, Dextroamphetamine and methylphenidate in the treatment of hyperactive/aggressive children, Pediatrics 53:236–241.PubMedGoogle Scholar
  341. Wolfensberger, W., and Menolascino, F., 1968, Basic considerations in evaluating ability of drugs to stimulate cognitive development in retardates Am. J. Mental Def. 73:414–423.Google Scholar
  342. Wong, G. H., and Cock, R. J., 1971, Long-term effects of haloperidol on severely emotionally disturbed children, Aust. N. Z. J. Psychiat. 5:296–300.Google Scholar
  343. Wyatt, G. L., 1969, Language Learning and Communication Disorders in Children, pp. 172–189, Free Press, New York.Google Scholar
  344. Zimmerman, F. T., and Burgemeister, B. B., 1958, Action of methylphenidylacetate (Ritalin) and reserpine in behavior disorders in children and adults, Am. J. Psychiat. 115:323–328.PubMedGoogle Scholar
  345. Zrull, J. P., Westman, J. C., Arthur, B., and Rice, D. L., 1964, A comparison of diazepam, D-amphetamine, and placebo in the treatment of the hyperkinetic syndrome in children, Am. J. Psychiat. 121:388–389.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1978

Authors and Affiliations

  • Daniel J. Safer
    • 1
  1. 1.Baltimore County Department of HealthRosedaleUSA

Personalised recommendations